ArticleFrontiers in molecular biosciences2025
A DNA2 mutation in the ATP-binding motif identified in a diagnostically unresolved individual.
Article in Frontiers in molecular biosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Many individuals with chronic, medically unexplained symptoms remain without a diagnosis, despite extensive clinical evaluations. Here, we present a framework integrating genome analysis with protein structural analysis to investigate such a case. Genome sequencing of a diagnostically unresolved individual identified a previously unreported DNA2 missense variant: T652R. This mutation lies within the Walker A motif (GxxxxGKT) of the helicase 1A domain, at an "x" position in the P-loop critical for ATP recognition. Structural analysis revealed that the introduced Arg652 sidechain displaces the conserved Lys654 from its canonical ATP-binding role and forms a new salt bridge with Asp973 in the helicase domain 2A. This interaction likely locks DNA2 in a closed conformation, impairing the dynamic domain movement essential for helicase activity. The case presented here demonstrates how structure-guided analysis of even a single missense variant can provide a basis of understanding the molecular origin of symptoms and help maximize the often underutilized diagnostic potential of genome sequencing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.